Legislation
to Address Medicare Fee Cuts Still Priority in Congress
With
the failure of the Senate to pass Medicare prescription drug
benefit legislation before the August congressional recess,
the prospects for such a bill being enacted this year seem
increasingly unlikely. There remains a commitment by Senate
lawmakers, however, to move forward with a legislative package
to prevent further cuts in physicians' Medicare fees. Sen.
Charles Grassley, the ranking Republican on the Senate Finance
Committee, and committee staffers have both indicated that
there is a good chance such a package will be taken up in
the fall, according to a Health News Daily report.
The exact vehicle for a package is still unclear at this point,
Sen. Grassley noted, but it could move as a stand-alone bill
or could be attached to other legislation, including any additional
Medicare prescription drug packages. In late June, the House
approved the "Medicare Modernization and Prescription
Drug Act of 2002," H.R. 4954, an ACC-endorsed bill that
would provide an approximate 6 percent increase in Medicare
physician payments over the next three years, as opposed to
the 14 percent cut projected under current law.
Anthem
Responds to Medical Societies' Complaints
Anthem has responded to a
complaint from the ACC, AMA, and 18 other state and specialty
societies about the insurer's practice of using contract provisions
that allow it to bundle CPT codes but do not allow physicians
any recourse to appeal the decisions. In its response, Anthem,
which operates Blue Cross and Blue Shield plans in eight states,
argued that "health care is a local activity" and
that "many of the detailed questions and concerns that
you raise
are thus best addressed at the local and
regional level." In a July
11 letter to Anthem, the medical societies also addressed
Anthem's improper bundling practices and improper recognition
and payment of modifiers, such as modifier -25, which is used
by cardiologists. Given Anthem's response, the ACC, through
its chapters and the National Specialty Society Payer Coalition,
of which the College is a member, will continue to push for
changes in Anthem reimbursement practices at both the local
and national levels.
Medical
Liability Reform Measure Voted Down
Even
before the Senate prescription drug benefit bill met its demise,
an amendment to the bill introduced by Sen. Mitch McConnell,
R-KY, that would have made reforms to the current medical
liability system was defeated. Despite lacking what many physician
groups consider to be a key component of any medical liability
legislation, a cap on noneconomic damages, the amendment did
not receive the support of a single Democrat. While the McConnell
amendment was defeated, "The
HEALTH Act of 2002," an ACC-supported medical liability
bill, is likely to come up for consideration in both the House
and Senate when Congress returns from its summer recess in
September. The House (H.R. 4600) and Senate (S. 2793) versions
of the bill are identical and include a $250,000 cap on noneconomic
damages in medical malpractice cases; the payment of judgments
over time rather than in a single lump sum; and allocate damages
only in proportion to a party's degree of fault. President
Bush has recently issued a proposed framework for medical
liability reform that includes many of the same provisions
as "The HEALTH Act."
Final
Hospital Inpatient Rule Includes DRGs for Drug-Eluting Stents
The
final 2003 hospital inpatient payment rule released on August
1 includes two new DRGs for drug-eluting stents that will
pay approximately 17 percent more than CMS currently does
for standard stentsor roughly $1,800 per procedure.
While the final rule takes effect on October 1, the DRGs for
the coated stents do not take effect until April 1, 2003.
The move by the CMS is surprising because no drug-eluting
stents have been approved by the FDA. The CMS noted in the
final rule, however, that results from recent
clinical trials presented at scientific meetings revealed
"virtually no in-stent restenosis in patients treated
with the drug-eluting stent," and that the agency recognized
"the potentially significant impact this technology may
conceivably have on the treatment of coronary artery blockages."
Implementation of the new DRGs assumes that the FDA will have
approved a drug-coated stent by the rule's effective date.
Nevada
Legislature Passes Liability Reform Bill
The
Nevada legislature last weekmeeting in a special summer
session called by Gov. Kenny Guinn, Rpassed
a medical liability reform bill. Nevada has been a microcosm
of the medical liability crisis, with OB/GYNs leaving the
state and trauma centers temporarily closing because physicians
couldn't afford or obtain liability insurance. The bill, if
signed by Gov. Guinn, will place a $350,000 cap on noneconomic
damages, although with several significant exceptions, including
cases in which the conduct of the defendant is determined
to constitute gross malpractice. The bill also holds defendants
liable only for their share of the fault in the disputed case,
allows for periodic payments of economic damages, and caps
civil damages at $50,000 for physicians practicing in a trauma
center, with the exception of gross negligence. According
to a Las Vegas Journal Review report, the bill also
contains provisions modeled after a Pennsylvania law that
requires mandatory reporting of medical errors to the state,
but without identifying the parties involved in the errors.
The Nevada Trial Lawyers Association has indicated that it
will challenge the law in court, the Associated Press reported.
ACC
Joins Other Specialty Groups at State Legislators Conference
For
the second year in a row, the ACC joined with 11 other medical
societies in a joint booth called "Physicians Advocating
for Patients" at the National Conference of State Legislatures
(NCSL) meeting in Denver, Colo. The exhibit offered the more
than 4,000 conference attendees, many of them state legislators
and their staff, a centralized source of information on state-level
issues of common interest to physicians, including medical
liability reform, patients' rights, medical research funding,
and access to quality health care. Joint booth participants
were deluged with positive comments from visitors about the
unified presence of the physician groups. ACC representatives
gave legislators and staff copies of the Digest
of State Health Polices, information on ACC's quality
initiatives, and the ACC patient brochure, Caring
for Your Heart. Visitors could also receive free screenings
for heart disease and breast cancer (based on family history),
vision, and glaucoma.
Wall
St. Journal Report Highlights Insurer "Bundling"
Practices
The
increasingly common HMO practice of bundling payments for
multiple procedures into the payment of just one of those
procedures hit the front pages of the Wall Street Journal
last week. Physicians have argued that the practice is unfair
and illegal and has cost them hundreds of millions in reimbursement.
Several physicians and physician groups have filed lawsuits
against Cigna and other insurers to recover unpaid expenses
and damages related to the practice. According to the Journal
report, the Florida attorney general's office is investigating
the issue, and the assistant U.S. attorney in Philadelphia
is also following the issue closely.
Judge
Clears Way for Discovery in State Medical Societies' Suit
Against HMOs
A
U.S. Federal judge in Miami has given five state medical societies
the go-ahead to begin "discovery" in a lawsuit they
have filed against some of the nation's biggest HMOs. The
ruling allows the societies and other physicians and states
that have joined in the suit to obtain documents and records
from the HMOs related to their reimbursement practices. Some
of the HMOs in
the suit include Aetna, United Healthcare, CIGNA, Humana
Health Plan, Inc, and Anthem Blue Cross Blue Shield.
Advocacy
Weekly is a product of the Advocacy Division of the American
College of Cardiology. Questions or comments regarding this
publication should be directed to the Advocacy Division
at 800-435-9203 or to advocacydiv@acc.org.
|